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Do Vascular Surgery Patients Need a Cardiology Work-up? A Review
of Pre-operative Cardiac Clearance Guidelines in Vascular Surgery
Farshad Abir, Iannis Kakisis and Bauer Sumpio
Department of Vascular Surgery, Yale University School of Medicine, 333 Cedar Street,
New Haven, CT 06510, U.S.A.
Objectives: to outline the appropriate pre-operative cardiac work-up for patients who are scheduled for major peripheral
vascular surgery.
Design: review of the literature.
Materials and Methods: a review of the literature focusing on studies that have correlated the pre-operative cardiac
work-up patients receive to the cardiac morbidity and mortality following vascular surgery. Only studies with level A
evidence were included.
Results: peri-operative beta blockade has been shown to decrease cardiac complications after vascular surgery in all risk
groups. Non-invasive cardiac testing is only necessary for patients in the intermediate/high risk group. Coronary
revascularization should only be considered after a positive non-invasive cardiac test.
Conclusions: patients must be risk stratified pre-operatively based on history and physical examination. Low risk patients
should receive peri-operative beta blockade only with no further non-invasive testing. On the other hand, intermediate and
high risk patients should undergo non-invasive cardiac testing before going to the operating room.
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As the U.S. population ages the number of vascular
surgery procedures continues to rise. Myocardial
infarction (MI) and congestive heart failure remain
the most common cause of death in the post-operative
patient.1 Numerous reports have also confirmed that
patients undergoing vascular reconstruction have
an elevated cardiac risk.2±4 A team approach emphas-
izing communication between the patient, primary
care physician, anesthesiologist, and surgeon is
required for successful peri-operative evaluation and
management of patients undergoing surgery.
When considering a patient for surgery a careful
pre-operative clinical evaluation is essential to reduce
post-operative cardiac complications. The history and
physical examination should focus on identifyingPlease address all correspondence to: Dr Bauer Sumpio, Depart-
ment of Vascular Surgery, Yale University School of Medicine, 137
FMB 333 Ceder Street, New Haven 06510, U.S.A.
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MI, angina pectoris, and congestive heart failure. Sig-
nificant comorbid diseases should also be identified,
such as, diabetes mellitus, renal insufficiency, and
chronic pulmonary disease. A pre-operative electro-
cardiogram (ECG) is helpful to recognize arrhythmias
and signs of old (Q waves) or current (ST segment
changes) cardiac ischemia. The physician should
assess the patient's functional capacity. The Duke
Activity Status Index (Table 1),39 and other activity
scales provide the surgeon with a set of questions to
determine a patient's functional capacity. These ques-
tions focus on everyday activities such as eating,
dressing, walking around the house, climbing a flight
of stairs, running a short distance and swimming.
Each of these activities is given a specific score. The
Duke Activity Status Index was developed to assess
functional capacity in a way that correlates with oxy-
gen uptake by weighting questions according to
known metabolic cost of each activity.rights reserved.
Table 1. Duke activity status index.
Can you . . . Weight
1. Take care of yourself that is, eating, dressing,
bathing, and using the toilet?
2.75
2. Walk indoors, such as around your house? 1.75
3. Walk a block or tow on level ground? 2.75
4. Climb a flight of stairs or walk up a hill? 5.50
5. Run a short distance? 8.00
6. Do light work around the house like dusting
or washing dishes?
2.70
7. Do moderate work around the house like
vacuuming, sweeping floors, carrying
in groceries?
3.50
8. Do heavy work around the house like
scrubbing floors, or lifting or moving
heavy furniture?
8.00
9. Do yard work like raking leaves weeding or
pushing a power mover?
4.50
10. Have sexual relations? 5.25
11. Participate in moderate recreational activities,
like golf, bowling, dancing, double tennis, or
throwing baseball or football?
6.00
12. Participate in strenuous sports like swimming,
singles tennis, football, and basketball or skiing?
7.50
Each question can be answered one of four ways, with each answer
having a weighted score:
A. Yes, with no difficulty 1
B. Yes, with some difficulty 2
C. No, I can't do this 3
D. Don't do this for other reasons 4
Total score is then calculated.
Table 2. Risk stratification.
Low risk
Advanced age
Abnormal ECG
Rhythm other than sinus
Low functional capacity
History of stroke
Uncontrolled hypertension
Intermediate risk
Prior MI
Diabetes mellitus
Compensated or prior CHF
Mild angina pectoris
High risk
Recent MI
Unstable or severe angina
Decompensated CHF
Significant arrhythmia
High grade AV block
Symptomatic arrhythmias in the presence of underlying
heart disease
Supraventricular arrhythmias with uncontrolled
ventricular rate
Severe valvular disease
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During the history and physical examination it is not
only important to identify heart disease, but it is
essential to gauge disease severity, stability, and prior
treatment. Once the patient's risk factors are identi-
fied, it is essential to determine whether the patient is
at high, intermediate, or low risk for peri-operative
cardiac complications. The American College of
Cardiology (ACC) and the American Heart Associa-
tion (AHA) published guidelines for risk stratification
of patients undergoing non-cardiac surgery (Table 2).5
The goal of risk stratification is to reduce overall mor-
bidity and mortality. Factors that help determine car-
diac risk include functional capacity, age, comorbid
disease (i.e. diabetes mellitus, renal insufficiency,
chronic pulmonary disease) and high risk surgery.
For patients who have undergone coronary revascu-
larization in the past 5 years, and their clinical status
has remained stable without recurrent symptoms/
signs of ischemia, further cardiac testing is not neces-
sary. If a patient had an adequate coronary evaluation
within the last two years and the findings were favor-
able, it is usually not necessary to repeat testing unless
there are new symptoms of coronary ischemia since
the previous evaluation.The information gathered from the history and
physical will help risk stratify the patient as either
low, intermediate or high risk for a peri-operative
ischemic event. Consideration for further diagnostic
testing is based on what risk category the patient is
placed. In the case of patients with one or more risk
factors, the most important issue to consider is how
the results of various cardiac tests will influence deci-
sion making and management.
Non-invasive Pre-operative Cardiac Testing
It is important to recognize which patients are most
likely to benefit from pre-operative coronary assess-
ment and treatment. Patients who fall into the low risk
category need no further evaluation.6 In these low risk
patients, the occurrence of myocardial ischemia on
stress testing has a low positive predictive value, and
may be associated with more false positive than true
positive results.25 Numerous studies have shown that
low risk patients have an extremely small risk of peri-
operative cardiac complications when treated with
peri-operative beta blockade only (please refer to the
medical therapy section for more details). Therefore,
the results of further cardiac testing should not change
the management in these patients. Hence, further test-
ing is not cost effective in this group. Patients who are
at intermediate or high risk of a peri-operative cardiac
complication warrant further testing, only if the find-
ing of stress induced myocardial ischemia, clinically
significant ventricular or valvular disease may lead toEur J Vasc Endovasc Surg Vol 25, February 2003
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therapy to decrease the risk of cardiac complications,
or a difference in peri-operative monitoring.
Non-invasive tests are available which assess left
ventricular function (radionuclide angiography), car-
diac ischemia (exercise or pharmacological stress test-
ing and ambulatory electrocardiographic monitoring),
or both (dobutamine stress echocardiography). It is
important realize that a non-invasive test may detect
a cardiac abnormality, but this by itself does not
always predict increased risk. Also, it must be stressed
that the results of non-invasive tests are open to inter-
pretation by the physician reviewing the study.7±9
Radionucleotide angiography and transthoracic
echocardiography are the major methods for assessing
left ventricular ejection fraction, but both tests have
never been shown to help predict post-operative myo-
cardial infarction and cardiac death.10±12 Exercise elec-
trocardiography is the least expensive non-invasive
test for myocardial ischemia. This test can be per-
formed in the outpatient setting by trained personnel
who are under the supervision of a physician. During
this test, the physician should be available in case of
an emergency. The rate of acute MI or death is about 1
per 2500 tests.37 A large amount of information can be
derived from an exercise test, such as, electrocardio-
graphic changes, a patient's symptoms and exercise
capacity, and the hemodynamic changes (e.g. heart
rate and blood pressure) that occur in response to
exercise. The data obtained from exercise electrocar-
diography can be integrated through the use of the
Duke treadmill score,38 which is calculated as follows:
duration of exercise in minutes ± (5 the maximal net
ST-segment deviation during or after exercise, in milli-
meters) ± (4 the treadmill angina index). The angina
index is assigned a value of 0 if angina is absent during
exercise, 1 if typical angina occurs during exercise, and
2 if angina is the reason the patient stopped exercising.
Exercise electrocardiography has a sensitivity of 68%
and specificity of 77% for the detection of coronary
artery disease.13,14 However, those patients who are
not at high risk for extensive coronary disease, the
sensitivity of exercise electrocardiography may be as
low as 45%.15
Stress single-photon-emission-computed tomography
(SPECT) uses radioactively labeled tracers (e.g. thal-
lium 201 or technetium 99) to assess myocardial per-
fusion and viability. The uptake of these agents by
myocardial cells depends on both the perfusion and
viability of that region of myocardium. The initial
distribution of these tracers is proportional to myocar-
dial blood flow, however the redistribution images,
which are taken 3±4 h later, reflect myocardial viability
and are unrelated to flow. A myocardial defect on anEur J Vasc Endovasc Surg Vol 25, February 2003initial scan that resolves on a delayed scan is an indi-
cation that the myocardium is viable. A defect that is
seen on both initial and delayed images suggests a
region of myocardium that has died, presumably sec-
ondary to a MI. Ischemia can be triggered by physical
exercise or pharmacological agents (e.g. dobutamine,
adenosine or dipyridamole). These three agents are
useful in patients who are unable to perform physical
exercise.16 Dobutamine is a positive ionotropic agent
that provokes ischemia by increasing myocardial
work, however adenosine and dipyridamole are vaso-
dilators that unmask coronary stenoses by increasing
flow in coronary arteries that are not diseased. SPECT
has higher sensitivity 88%, and similar specificity for
the detection of coronary artery disease when com-
pared to exercise electrocardiography.13,16
A final mode of non-invasive testing is stress echo-
cardiography. Myocardial stress can be triggered by
exercise or pharmacological agents to trigger ische-
mia.17 Echocardiographic images obtained at rest
and during stress are compared, and areas, which
develop wall motion abnormalities during stress, are
considered positive. In addition, this test provides
information on left ventricular and cardiac valve func-
tion. The sensitivity is 77% which is slightly lower
than SPECT, but still higher than exercise electrocar-
diography.13,16 Exercise echocardiography has a spe-
cificity of 88% for coronary artery disease and this is
higher than either SPECT or exercise electrocardio-
graphy.18 The function, sensitivity and specificity of
the various non-invasive cardiac tests are summarized
in Table 3.
Unfortunately, to date no clinical trials have been
performed in patients with suspected coronary artery
disease comparing patient outcomes randomly
assigned to the three non-invasive cardiac tests. The
literature consistently shows that SPECT and stress
echocardiography provide more information than
exercise electrocardiography alone.13,16,19 However,
even if a test provides more information it does not
mean it is the most appropriate test. No single test has
been proven to be superior overall. A substantial pro-
portion of patients with peripheral vascular disease
(30±70%) cannot attain target heart rates and therefore
cannot complete the exercise portion of the test
adequately for diagnosis.20,21 Obviously, in a patient
who does not have the functional capacity to partici-
pate in exercise electrocardiography, this test is not an
option. Further more, in patients whose ECG is unin-
terpretable should not undergo exercise electrocardio-
graphy. In patients being considered for SPECT vs
stress echocardiography the test that is most estab-
lished and available at a given institution should
be used.
Table 4. The effect of bisoprolol on peri-operative cardiac compli-
cations in high risk patients undergoing vascular surgery.
No. of
patients
Cardiac
death %
Non-fatal
MI %
Overall
cardiac
events %
p value Level of
evidence
Bisoprolol 59 3.4 0 3.4 50.001 A1a
Placebo 53 17 17 34
Polderman et al.24
Table 3. Functions of non-invasive cardiac tests and the specificity and sensitivity for the detection of coronary artery
disease.
Diagnostic test Function Specificity % Sensitivity %
Radionucleotide angiography Assess LVEF N/A N/A
Transthoracic echocardiography Assess LVEF and cardiac valves N/A N/A
Exercise electrocardiography Detects CAD and assesses
functional capacity
77 68
SPECT Detects CAD 77 88
Stress echocardiography Detects CAD and assesses LVEF
and cardiac valves
88 76
LVEF left ventricular ejection fraction.CAD coronary artery disease.
Table 5. The effect of beta blockers on peri-operative cardiac
complications in low and intermediate/high risk patients
undergoing vascular surgery.
Beta
blockers
Placebo p value Level of
evidence
Low risk patients with
cardiac complications
0.8%
(2/363)
2.3%
(20/855)
50.001 A1b
Intermediate/high risk
patients with
cardiac complications
2.0%
(1/50)
10.6%
(5/47)
50.001
Boersm et al.25
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The ability of beta-blockers to reduce the peri-operative
risk of cardiac complications has been extensively
documented. The first randomized trial showing the
protective effects of peri-operative beta-blockade
in high risk patients undergoing non-cardiac surgery
used atenolol in 200 high risk patients.22 Atenolol was
administered intravenously or orally beginning two
days pre-operatively and continuing for seven days
post-operatively, and this reduced the incidence of
peri- and post-operative myocardial ischemia by
30±50%.23
Poldermans et al.24 performed a randomized multi-
center trial assessing the effect of pre-operative beta
blockers in high risk patients undergoing vascular
surgery (Table 4). A total of 846 patients were enrolled
in this study. Of the 846 patients, 173 had positive
results on dobutamine echocardiography. Fifty-nine
patients were randomly assigned to receive bisopro-
lol, and 53 to receive standard care without beta block-
ade. The remaining 61 patients were excluded from
the study because they were either already taking
beta blockers or they had extensive wall motion
abnormalities at either rest or during stress testing.
Two patients in the bisoprolol group died of cardiac
causes (3.4%), as compared to the standard care group
(17%). Non-fatal MI did not occur in the bisoprolol
group, but nine patients in the standard care group
had a non-fatal MI. Therefore, cardiac death or non-
fatal MI occurred in 3.4% of patients in the bisoprolol
group compared to 34% in the standard care group.
This study demonstrated the beneficial effect of pre-
operative beta blockade in high risk patients
undergoing vascular surgery.
Recently Boersm et al.25 conducted a cohort multi-
center study assessing the effects of peri-operative
beta blockers in low, intermediate, and high risk
patients undergoing major vascular surgery (Table 5).
A total of 1351 patients undergoing vascular surgery
were enrolled in the study, and 1118 patients metclinical criteria for low risk to have a peri-operative
cardiac complication. In this low risk group, 263
patients receive peri-operative beta blockade and 855
patients did not. Cardiac complications occurred in
0.8% (2/263) of patients receiving beta blockers, com-
pared to 2.3% (20/855) of patients who did not receive
beta blockers. Patients in the intermediate or high risk
category also benefited from peri-operative beta
blockade. In this group, cardiac complications
occurred in 2% of patients receiving beta blockers,
compared to 10.6% in patients not receiving beta
blockade. The study demonstrated the beneficial effect
of peri-operative beta blockade in reducing cardiac
complications in all patients undergoing vascular
surgery irrespective to risk category.
Coronary Revascularization
Unfortunately, there have not been any randomized or
controlled trials assessing the benefit of pre-operativeEur J Vasc Endovasc Surg Vol 25, February 2003
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results of several retrospective cohort studies have
been published.26±28 One of the studies compared the
results of pre-operative percutaneous transluminal
coronary angioplasty (PTCA) to coronary artery
bypass surgery (CABG) in patients undergoing elec-
tive abdominal aortic aneurysm repair.27 The authors
retrospectively reviewed the records of 2452 patients
who had abdominal aortic aneurysm repair. One hun-
dred patients (4.1%) had coronary revascularization
(86 patients had CABG and 14 had PTCA) mostly for
symptomatic CAD. There were no peri-operative
deaths in the coronary revascularization group, com-
pared with 2.9% peri-operative mortality for the entire
group. Huber28 conducted a retrospective study on
50 patients who were at high risk for peri-operative
cardiac complications (e.g. multivessel disease and
abnormal non-invasive studies) who had PTCA before
non-cardiac surgery. In the patients who received
PTCA the peri-operative MI rate was 5.9% and the
mortality rate was 1.9%. There was no control group,
therefore whether or not these results differ from what
may have been occurred without PTCA is uncertain.
Due to the limited data, prophylactic pre-operative
PTCA cannot be advocated in trying to reduced peri-
operative cardiac complications in patients under-
going major vascular surgery. Until data proving the
contrary, the indications of PTCA in the pre-operative
vascular patient is the same as those developed by the
joint ACC/AHA Task Force outlining the indication
for PTCA in the general patient population.29
As is the case with PTCA, there are no randomized
controlled clinical trials proving the benefit of prophy-
lactic CABG to lower the peri-operative cardiac risk in
patients undergoing major vascular surgery. However,
several retrospective studies have shown that patients
undergoing CABG before non-cardiac surgery have
the same peri-operative mortality as patients who
have no clinical signs of CAD.30±32 The largest study
assessed 3368 patients with known CAD undergoing
non-cardiac surgery being assigned either to medical
therapy or CABG in the Coronary Artery Surgery
Study (CASS).33 The patients who underwent CABG
before their non-cardiac surgery had a peri-operative
mortality rate of 1.7% compared to 3.3% in patients
who received medical therapy.
Foster et al.34 conducted a retrospective analysis of
1600 patients from the CASS registry who eventually
underwent major vascular surgery. This study
revealed significant differences in mortality between
patients who underwent pre-operative CABG (0.9%)
and those who had not (2.4%). However, there also
was a 2.3% mortality rate associated with CABG.
In patients in whom coronary revascularization isEur J Vasc Endovasc Surg Vol 25, February 2003indicated, timing of the procedure depends on the
urgency of the vascular surgical procedure balanced
against the stability of the CAD. Patients undergoing
elective major vascular surgery who are found to
have high risk coronary disease and whom long-
term outcome would be improved by CABG, should
generally undergo revascularization before there
elective surgery.5
Discussion
Cardiac complications are the leading cause of mor-
bidity and death in patients undergoing vascular sur-
gery.1 Several studies have shown that patient's
undergoing major vascular surgery have an increased
risk of peri-operative cardiac complications, com-
pared to patient's who have other types of non-cardiac
surgery.3,4 This phenomenon is most likely explained
by the known association between coronary disease
and peripheral vascular disease.
Roughly 10% of patients will be considered to be at
high risk for cardiac complications after clinical evalua-
tion.35 Among unselected patients undergoing vascu-
lar surgery, an additional 9±20% may be reclassified as
high risk by non-invasive testing.36 In most ambula-
tory patients, the test of choice is exercise electro-
cardiography, which provides both an estimate of
functional capacity and can detect myocardial ische-
mia. In patients with either uninterpretable or major
abnormalities on ECG, or patients who cannot meet
the physical requirements of the exercise portion of
the exam, should undergo stress echocardiography or
SPECT.5 Patients with evidence of stress induced
myocardial ischemia on non-invasive testing have an
8±38% risk of cardiac death or MI within 30 days after
surgery.25,36 In contrast, in patients without evidence
of stress induced myocardial ischemia on non-
invasive testing, have cardiac complication rates the
range of 0±5%.25 Previously mentioned studies have
proven that the use of peri-operative beta-blockade
reduces the incidence of cardiac complications post-
operatively in all patients undergoing major vascular
surgery.
For the small percentage of patients who are at high
risk and have symptoms of unstable angina or
residual ischemia after recent MI pre-operatively,
it may be appropriate to proceed directly to coronary
angiography rather than perform a non-invasive
study.5 Coronary revascularization via PTCA or
CABG should only be performed in patients who
meet the criteria for the respective procedures inde-
pendent of the proposed vascular surgery procedure.
The benefit of prophylactic coronary revascularization
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clinical trial.
Conclusion
When a surgeon is evaluating a patient for major vas-
cular surgery the first step is to risk stratify the patientFig. 1. Algorithm for cardiac evaluation and management of vascularbased on history and physical examination (Fig. 1). If
a patient is determined to be low risk then no
non-invasive testing is needed, but peri-operative
beta-blockade should be started in the absence of
contraindications. However, if a patient is determined
to be at intermediate or high risk for a peri-operative
cardiac complication then non-invasive cardiac testingpatients.
Eur J Vasc Endovasc Surg Vol 25, February 2003
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patient may proceed to surgery with peri-operative
beta-blockade. On the other hand, if the test is positive
then the patient should undergo cardiac catheteriza-
tion. A patient with a negative cardiac catheterization
should undergo surgery with peri-operative beta-
blockade. If it is found that the patient has one or
two vessel disease then PTCA should be performed
followed by surgery with peri-operative beta-
blockade. Lastly, in patients with left main coronary
artery or severe three vessel disease should have a
CABG followed by surgery with peri-operative
beta-blockade.
With the increased patency rates for coronary artery
stents in patients with significant coronary artery
disease, the AHA/ACC may have to re-evaluate
their guidelines/recommendations for the time period
of re-testing a patient who has already undergone
coronary revascularization. Currently, the AHA/
ACC guidelines state that a patient who has had cor-
onary revascularization within the last 5 years and is
asymptomatic needs no further diagnostic testing
before surgery. However, the recent advent of endo-
luminal brachytherapy, gene therapy, and pharmaco-
logically coated stents (i.e. actinomycin D, taxol, and
sirolimus) aimed at reducing intimal hyperplasia in
blood vessels, and hence increasing stent patency rates
may increase the time period before cardiac testing is
necessary after coronary revascularization.
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